Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 62, Issue 14, 2013, Pages 1252-1259

  Kubo, Toru ^a   Kitaoka, Hiroaki ^a   Yamanaka, Shigeo ^a   Hirota, Takayoshi ^a   Baba, Yuichi ^a   Hayashi, Kayo ^a   Iiyama, Tatsuo ^a   Kumagai, Naoko ^a   Tanioka, Katsutoshi ^a   Yamasaki, Naohito ^a   Matsumura, Yoshihisa ^a   Furuno, Takashi ^a   Sugiura, Tetsuro ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

biomarker; high sensitivity cardiac troponin T; hypertrophic cardiomyopathy; prognosis

Indexed keywords

TROPONIN T;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM;

2-D; BIOMARKER; CI; CONFIDENCE INTERVAL; FRACTIONAL SHORTENING; FS; HAZARDS RATIO; HCM; HIGH-SENSITIVITY CARDIAC TROPONIN T; HR; HS-CTNT; HYPERTROPHIC CARDIOMYOPATHY; ICD; IDI; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INTEGRATED DISCRIMINATION IMPROVEMENT; LEFT VENTRICULAR; LEFT VENTRICULAR END-DIASTOLIC DIAMETER; LEFT VENTRICULAR END-SYSTOLIC DIAMETER; LV; LVEDD; LVESD; MAGNETIC RESONANCE IMAGING; MRI; NEW YORK HEART ASSOCIATION; NYHA; PROGNOSIS; TWO-DIMENSIONAL; VENTRICULAR TACHYCARDIA; VT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TROPONIN T; YOUNG ADULT;

EID: 84884561862     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.055     Document Type: Article

References (28)

1. P. Spirito, C.E. Seidman, W.J. McKenna, and B.J. Maron The management of hypertrophic cardiomyopathy N Engl J Med 336 1997 775 785
2. B.J. Maron Hypertrophic cardiomyopathy: A systematic review JAMA 287 2002 1308 1320
3. B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice guidelines J Am Coll Cardiol 42 2003 1687 1713
4. F. Cecchi, I. Olivotto, A. Montereggi, G. Santoro, A. Dolara, and B.J. Maron Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population J Am Coll Cardiol 26 1995 1529 1536
5. B.J. Maron, S.A. Casey, L.C. Poliac, T.E. Gohman, A.K. Almquist, and D.M. Aeppli Clinical course of hypertrophic cardiomyopathy in a regional United States cohort JAMA 281 1999 650 655
6. M.J.M. Kofflard, F.J. Ten Cate, C. van der Lee, and R.T. van Domberg Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration J Am Coll Cardiol 41 2003 987 993
7. B.J. Maron, I. Olivotto, and P. Spirito Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population Circulation 102 2000 858 864
8. T. Kubo, H. Kitaoka, and M. Okawa Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy: Results from Kochi RYOMA Study Circ J 73 2009 1599 1605
9. A. Matsumori, Y. Furukawa, and K. Hasegawa Epidemiologic and clinical characteristics of cardiomyopathies in Japan-results from nationwide surveys Circ J 66 2002 323 336
10. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
11. P.M. Elliott, B.J. Gimeno, N.G. Mahon, J.D. Poloniecki, and W.J. McKenna Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424
12. I. Olivotto, F. Cecchi, S.A. Casey, A. Dolara, J.H. Traverse, and B.J. Maron Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524
13. B.J. Maron, I. Olivotto, and P. Bellone Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 301 307
14. C. Autore, P. Bernabo, C.S. Barilla, P. Bruzzi, and P. Spirito The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms J Am Coll Cardiol 45 2005 1076 1080
15. Y. Sato, T. Yamada, and R. Taniguchi Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes Circulation 103 2001 369 374
16. T.B. Horwich, J. Patel, W.R. MacLellan, and G.C. Fonarow Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure Circulation 108 2003 833 838
17. C. Kawahara, T. Tsutamoto, and K. Nishiyama Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy Circ J 75 2011 656 661
18. K. Thygesen, J.S. Alpert, H.D. White, and Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2004 2173 2195
19. A.K. Saenger, R. Beyrau, and S. Braun Multicenter analytical evaluation of a high-sensitivity troponin T assay Clin Chim Acta 412 2011 748 754
20. H. Okura, R. Suzuki, S. Sugibayashi, M. Yoshika, and H. Takahashi Performance and clinical utility of a high-sensitivity troponin T assay Rinsyo Byori 60 2012 407 413 (in Japanese)
21. V. Moreno, D. Hernandez-Romero, and J.A. Vilchez Serum levels of high-sensitivity troponin T: A novel marker for cardiac remodeling in patients with hypertrophic cardiomyopathy J Card Fail 16 2010 950 956
22. S.E. Petersen, M. Jerosch-Herold, and L.E. Hudsmith Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging Circulation 115 2007 2418 2425
23. J.C. Moon, E. Reed, and M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
24. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, and D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
25. A.S. Adabag, B.J. Maron, and E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
26. M.S. Maron, E. Appelbaum, and C.J. Harrigan Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
27. S. Leonardi, C. Raineri, and G.M. De Ferrari Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy Eur Heart J 30 2009 2003 2010
28. R. O'Hanlon, A. Grasso, and M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874